- Johnson & Johnson's (NYSE:JNJ) CEO Alex Gorsky will step away from his role in January 2022 in favor of Joaquin Duato, the vice-chairman of the executive committee.
- He served as CEO for nine years and will become J&J's executive chairman effective January 3.
- Gorsky joined up with Janssen back in 1988 as a sales representative before climbing his way up the ladder at J&J before eventually being named CEO in 2012.
- In an interview with the Wall Street Journal, Gorsky said he was making the move due to "health issues."
- During his run atop J&J, Gorsky oversaw the Company's vigorous legal defense against talc class action suits and the fallout from the nation's opioid epidemic.
- Related: Opioid Settlement Of $26B Between Drug Companies, States.
- Also See: US House Panel Asks JNJ For Documents Over Talc Liabilities Bankruptcy Plan.
- Price Action: JNJ shares closed 0.78% at $178.57 on Thursday.
Loading...
Loading...
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
